Key result
MLKL brace mutations cause lethal inflammation in mice and are enriched ~12-fold in CRMO patients.
Why the study?
The impact of a missense mutation in the MLKL brace region on necroptosis and its role in lethal neonatal inflammation and hematopoietic dysfunction was unclear.
A missense mutation in the MLKL brace region confers constitutive killing activity, leading to lethal neonatal inflammation in mice and potentially modulating disease in human autoinflammatory conditions.
Answers are grounded in this paper and cite their sources.
MlklD139V mice model MLKL-driven postnatal inflammation; leaves open human disease relevance and therapeutic targeting.
MLKL is the essential effector of necroptosis, a form of programmed lytic cell death. We have isolated a mouse strain with a single missense mutation,MlklD139V, that alters the two-helix ‘brace’ that connects the killer four-helix bundle and regulatory pseudokinase domains. This confers constitutive, RIPK3 independent killing activity to MLKL. Homozygous mutant mice develop lethal postnatal inflammation of the salivary glands and mediastinum. The normal embryonic development ofMlklD139Vhomozygotes until birth, and the absence of any overt phenotype in heterozygotes provides important in vivo precedent for the capacity of cells to clear activated MLKL. These observations offer an important insight into the potential disease-modulating roles of three common humanMLKLpolymorphisms that encode amino acid substitutions within or adjacent to the brace region. Compound heterozygosity of these variants is found at up to 12-fold the expected frequency in patients that suffer from a pediatric autoinflammatory disease, chronic recurrent multifocal osteomyelitis (CRMO).
No takes yet. Share an insight, caveat, or question.
Hildebrand et al. (2020) studied Chronic recurrent multifocal osteomyelitis (CRMO) and neonatal inflammation (n=128). MLKL brace region mutations (e.g., MlklD139V in mice, compound heterozygous variants in humans) vs. Wild-type MLKL was evaluated on Frequency of compound heterozygous MLKL brace variants in CRMO patients compared to healthy controls. A missense mutation in the MLKL brace region causes constitutive activation and lethal neonatal inflammation in mice, and compound heterozygosity for human MLKL brace variants is enriched up to 12-fold in patients with chronic recurrent multifocal osteomyelitis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: